Get this report today!
Table of Contents
During 2011 we witnessed the segmentation of the biotechnology industry as had long been forseen, drawn farther afield from its initial drug focus into areas such as “cleantech” and chemical manufacturing.
While American Recovery and Reinvestment Act (ARRA) funds helped foster drug research and development, we noticed surprising emphasis on low-possibility-of-success (POS) areas such as antineoplastic and immunomodulating agents, contrasting with smaller sums being sent into higher POS fields, such as acute diseases or dermatology. This somewhat swinging-for-the-fences mentality has a rationale in that if successful these products have much lower post launch competition. But if uncoupled to creative thinking at the R&D stage, one wonders what the ultimate ROI will be for taking this risk, and if patent expiration desperation is fueling this trend. Perhaps significantly, the sports world has names and faces of major league pitchers who have gone ahead with stem cell treatments, with the hopes of resurrecting lucrative careers. Mainstream acceptance of the risk involved in immature therapeutics surely paves the way for more clinical trials and regulatory urgency.
Regarding segmentation, we see many patents and venture capital dollars flowing into synthetic biology applications and “plants engineered to replace oil” efforts, such as algae biofuels and synthetic photosynthesis. The term “Biobrick” has come into common usage and will certainly not fade anytime soon.
This Biotechnology Research Review provides a sampling of the type of quantitative market information, analysis and guidance that has been aiding business decision making since BCC was founded in 1971. It includes highlights from the following reports published in 2011:
Polymerase Chain Reaction (PCR) Technologies and Global Markets
Biobanking: Technologies and Global Markets
Global Biochip Markets: Microarrays and Lab-on-a-Chip
Next-Generation Cancer Diagnostics: Technologies and Global Markets
RNAi Drug Delivery: Technologies and Global Markets
Stem Cell Therapeutics for Oncology: Technologies and Global Markets
Flow Cytometry: Products, Technologies and Global Markets
Sample Preparation in Genomics, Proteomics, and Epigenomics: Global Markets
Talk to Robyn
00 1 718 213 49 04
The Largest Collection of Market Research Reports
From +200,000 authoritative sources
"Analytical Tool- Cancer Immunotherapy" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in immunotherapy drug development for the treatment of cancer. It ...
"Analytical Tool - Cancer Therapeutic Antibodies" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in antibody drug development for the treatment of cancer. ...
Cancer immunotherapy offers an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. In this Drug Pipeline Update BioSeeker brings together the ...
... Stanton l. Gerson, md mesenchymal stem cells: clinical application and outlook the cwru experience asa & patricia shiverick and jane shiverick (tripp) professor of hematological oncology ...
... Endothelial progenitor cells Replace endothelial cells Epidermal stem cells Replace keratinocytes Gastrointestinal crypt cells Replace gastrointestinal epithelial cells Hematopoetic stem cells ...
... Cells image from the university of wisconsin-madison cardiovascular cell therapy research network (cctrn) 8 to promote and accelerate clinical research in the evaluation of novel cell therapy ...
Reportlinker.com © Copyright 2013. All rights reserved.